Assist. Prof. Dr Marco Narducci | Neuropharmacology | Best Research Article Award |

Temple University, Japan

Professional Profiles:

👨‍🎓 Bio Summary:

Assist. Prof. Dr. Marco Narducci is a distinguished academic and industry expert specializing in neuropharmacology, strategic innovation, and interdisciplinary research. With a passion for bridging science and business, he has developed novel therapies, founded startups, and led groundbreaking research at the intersection of biotechnology and marketing strategy. His global career spans academia and industry, with a focus on inspiring the next generation of leaders through innovative teaching and impactful research.

🎓 Educational Background:

Ph.D. in Neuropharmacology (University of Ferrara, Italy): Focused on innovative therapies for psychiatric and neurological disorders.

Ph.D. in Neuroaffective Treatments (International Christian University, Japan): Explored treatments for overcoming addictive behaviors.

Master’s in Strategic Marketing and New Product Development (Istituto Europeo di Design, Italy): Specialized in marketing innovations.

Master’s in Environmental Social Science (University of Liverpool, UK): Examined the intersection of environmental and social sciences.

Bachelor’s in Health Communication (Eastern Washington University, USA): Combined communication strategies with health sciences.

🔍 Research Focus:

Dr. Narducci’s research integrates neuropharmacology, biopharmaceutical innovation, and market-driven strategies. His work emphasizes developing advanced neuroaffective therapies, crafting corporate acceleration strategies for startups, and exploring the role of interdisciplinary approaches in addressing global health challenges.

🏆 Honors & Awards:

Innovator in Biotech and Neuromarketing: Recognized for founding three university spin-offs and filing four industrial patents.

Global Leadership: Held senior roles in prestigious organizations, contributing to impactful advancements in biopharma and strategic marketing.

💼 Professional Experience:

Assistant Professor (Temple University, Japan): Focused on corporate strategies for biopharma startups and neuromarketing.

Founder & Scientific Director (UniChem Estense SRL, Italy & Japan): Pioneered advanced biotechnologies and medical foods.

Scientific Director (Meydan Group, UAE): Led innovation-driven projects for food and pharmaceutical manufacturing.

Chief Scientific Officer (Fuji Chemical Industries, Japan): Oversaw research in pharmaceuticals and nutraceuticals.

📚 Top Noted Publications :

The Evolution of Ketosis: Potential Impact on Clinical Conditions
Authors: LN Dilliraj, G Schiuma, D Lara, G Strazzabosco, J Clement, PP Giovannini, M Narducci, et al.
Citations: 33
Journal: Nutrients
Index: 14(17), 3613
Year: 2022

Nicotinamide Adenine Dinucleotide: The Redox Sensor in Aging-Related Disorders
Authors: G Schiuma, D Lara, J Clement, M Narducci, R Rizzo
Citations: 6
Journal: Antioxidants & Redox Signaling
Index: N/A
Year: 2024

Non-Classical HLA Class I Molecules and Their Potential Role in Viral Infections
Authors: S Beltrami, S Rizzo, G Strazzabosco, V Gentili, A Alogna, M Narducci, et al.
Citations: 5
Journal: Human Immunology
Index: 84(8), 384-392
Year: 2023

An Alternative Enzymatic Route to the Ergogenic Ketone Body Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
Authors: F Zaccone, V Venturi, PP Giovannini, C Trapella, M Narducci, H Fournier, et al.
Citations: 5
Journal: Catalysts
Index: 11(1), 140
Year: 2021

Natural Astaxanthin, Antioxidant Protection Power for Healthy Eyes
Authors: GA Serrano, M Narducci
Citations: 5
Journal: Agro Food Industry High Technology
Index: 25, 11-14
Year: 2014

Going Radical, Risky or Random?: The Link Between Mood-Swings and Thought-Action Turnabouts: Field-Experiments in Retail Shopping and Online Gambling
Authors: M Narducci
Citations: 1
Journal: 国際基督教大学 (International Christian University)
Index: N/A
Year: 2012

Conclusion:

Marco Narducci, Ph.D., is a compelling candidate for the “Research for Best Research Article Award.” His interdisciplinary approach, global expertise, and demonstrated innovation in neuropharmacology and biotech make him well-suited for recognition. However, to maximize his chances:

Emphasis should be placed on high-impact, peer-reviewed publications.

A focused narrative highlighting his most significant and transformative research contributions should be presented.

Overall, Marco’s combination of academic rigor, industry relevance, and innovative research positions him as a strong contender for the award.

Dr Shahar Shelly | Neurology | Best Researcher Award |

Rambam Medical Center,Israel

Professional Profiles:

SCOPUS

ORCID

GOOGLE SCHOLAR

👨‍🎓 Bio Summary:

Dr. Shahar Shelly is a renowned neurologist and researcher specializing in neuroimmunology, neuromuscular disorders, and cutting-edge diagnostic and therapeutic approaches. He is the Chair of the Neurology Department at Rambam Medical Center and serves as the President of Israel’s Neuromuscular Society. Dr. Shelly is also an Assistant Professor at the Technion Institute of Medicine and Science and the Mayo Clinic College of Medicine. With a proven track record of groundbreaking research, leadership, and clinical excellence, he is dedicated to advancing the understanding and treatment of neurological diseases.

🎓 Educational Background:

Dr. Shelly completed his medical education at the University Medical School of Hungary, graduating Summa Cum Laude in 2012. He pursued an internship at Shamir Medical Center in Israel, earning Cum Laude honors. His advanced training includes a residency in neurology at Sheba Medical Center, followed by prestigious fellowships at Mayo Clinic in neuroimmunology and neuromuscular disorders, where he gained expertise in electrophysiology, nerve, and muscle diagnostics.

🔍 Research Focus:

Dr. Shelly’s research integrates big data analytics with molecular biology to uncover biomarkers and therapeutic targets for neurological disorders. His work spans early disease diagnosis, immune-modulating therapy response, and potential gene knockdown treatments. Notable achievements include discovering a patentable antigen, Neurochondrin, and conducting influential studies on the impact of titanium nanoparticles on the blood-brain barrier. His research aims to bridge the gap between laboratory discoveries and clinical applications.

🏆 Honors & Awards:

Dr. Shelly has received numerous accolades, including the Israel Medical Association Fellowship Award for outstanding promise in medicine, the Molivich Award for clinical and research excellence, and the Best Abstract and Research Study Award from the American Academy of Neurology. He has also been recognized for his exceptional academic achievements, such as ranking first in his neurology board exams and receiving Summa Cum Laude honors during his medical studies.

💼 Professional Experience:

Dr. Shelly has held various leadership roles, including Chair of the Neurology Department and Head of the Neuromuscular Division at Rambam Medical Center. He also leads the Neuroimmunology Laboratory at the Technion Institute of Medicine and is a regional board representative for hereditary muscle diseases for the RYR1 Foundation. As a faculty member at the Mayo Clinic and Technion Institute, he combines clinical practice with education and research, mentoring the next generation of neurologists.

📚 Top Noted Publications :

Prolactin and Autoimmunity

Authors: S. Shelly, M. Boaz, H. Orbach

Journal: Autoimmunity Reviews

Citations: 306

Index: 11(6-7), A465-A470

Year: 2012

Autonomic Dysfunction Following COVID-19 Infection: An Early Experience

Authors: K. Shouman, G. Vanichkachorn, W.P. Cheshire, M.D. Suarez, S. Shelly, et al.

Journal: Clinical Autonomic Research

Citations: 286

Index: 31, 385-394

Year: 2021

Thymoma and Autoimmunity

Authors: S. Shelly, N. Agmon-Levin, A. Altman, Y. Shoenfeld

Journal: Cellular & Molecular Immunology

Citations: 238

Index: 8(3), 199-202

Year: 2011

Immune Checkpoint Inhibitor-Associated Myopathy: A Clinicoseropathologically Distinct Myopathy

Authors: S. Shelly, J.D. Triplett, M.V. Pinto, M. Milone, F.E. Diehn, A. Zekeridou, et al.

Journal: Brain Communications

Citations: 77

Index: 2(2), fcaa181

Year: 2020

Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study

Authors: S. Shelly, M.M. Mielke, J. Mandrekar, M. Milone, F.C. Ernste, E. Naddaf, et al.

Journal: Neurology

Citations: 54

Index: 96(21), e2653-e2661

Year: 2021

Conclusion:

Dr. Shahar Shelly is a highly suitable candidate for the Best Researcher Award, given his outstanding research accomplishments, leadership, and innovative contributions to neurology and neuroimmunology. His ability to integrate cutting-edge methodologies, such as big data and molecular insights, with a strong focus on translational medicine sets him apart as a leader in his field. Addressing the areas for improvement can further solidify his standing as a globally recognized researcher.